YuX., LiuJ., QiuH., HaoH., ZhuJ., & PengS. (2020). Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer. Bosnian Journal of Basic Medical Sciences. https://doi.org/10.17305/bjbms.2020.4746